Personalis, Inc. (PSNL) income statement
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30345% above fair value
$14.98+0.18 (+1.22%)
Close on Nov 18, 2026Market cap $1.60BP/E –Yield –
Personalis, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 12.7%
- Operating margin
- -164.1%
- Net margin
- -153.8%
- Return on equity, FY2025
- -35.0%
Financial strength
- Current ratio
- 5.28
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 202.6%
Valuation
- P/E ratio
- –
- Price to sales
- 22.96
- Price to book
- 6.80
- Dividend yield
- –
See a number that looks wrong?